07
Feb
2012
03
Feb
2012
05
Aug
2011
05
Aug
2011
Posted in I - Series D, Q - 2Q10, R - INTERNATIONAL, X - Device (Imaging), X - Device (Neuromod)
Nexstim (Finland) a commercial-stage developer of non-invasive brain imaging technologies focused on cortical mapping prior to surgery, closed a $2.8M Series D financing, bringing the total round to $19.2M. Participants include Capricorn Health-tech Fund, Tekes, HealthCap, Sitra, Finnish Industry Investment, Lundbeckfond Ventures and Ilmarinen.
20
May
2011
06
Jan
2011
16
Dec
2010
05
Dec
2010
Posted in I - Series C, Q - 4Q10, R - INTERNATIONAL, X - Device (Imaging), X - Device (UltraSound)
SuperSonic Imagine (France) a commercial-stage medical device thearagnotic imaging company focused on the ultrasound visualization and measurement of tissue elasticity, closed a $25M Series C financing. Participants include Edmond de Rothschild Investment Partners, Auriga Partners, Credit Agricole Private Equity, NBGI Ventures, BioAm, Wellington Partners Venture Capital and iXO Private Equity.
10
Nov
2010
21
Jul
2010
22
Jan
2010
Posted in I - Series B, Q - 4Q09, R - INTERNATIONAL, X - Device (Imaging)
ActiView (Israel) a development-stage medical device company focused on optical guidance systems for use in CT fluoroscopy and MRI procedures, closed a $5M Series B financing. Participants include7 Health Ventures, Ofer HiTech and Evergreen Venture Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb
21
Jan
2010
Posted in I - Series A, Q - 4Q09, R - SOUTH EAST, X - Biomarker, X - Device (Imaging), XX - TN
ABT Molecular Imaging (Knoxville, TN) medical imaging company developing a production platform to generate unit doses of molecular imaging drugs for positron emission tomography (PET) scanning at the point of use, closed a $9M Series A financing. Participants include Intersouth Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.
02
Nov
2009
Posted in I - Series E, Q - 3Q09, R - NORTH WEST, X - Device (Imaging), X - Device (Radiotherapy), XX - WA
Calypso Medical Technologies (Seattle, WA) a commercial-stage medical device company focused on implantable sensor electromagnetic transponders, to accurately and continuously pinpoint the location of tumors in real-time during radiation therapy delivery, closed a $50M Series E financing. Participants include Skyline Ventures, Frazier Healthcare Ventures, Bay City Capital and InterWest Partners.